Interaction of Spironolactone with Rat Skin Androgen Receptor

    Andrée Boisselle, F. T. Dionne, Roland R. Tremblay
    TLDR Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.
    The study investigated the characteristics of the androgen receptor (AR) in the dorsal skin of male rats, finding that it shares similarities with the AR in rat prostate in terms of affinity constant, binding specificity, and sedimentation profile. The research showed that the skin AR is largely occupied by endogenous hormones from gonadal or adrenal sources. The study also demonstrated that administering spironolactone or its active metabolite canrenone to castrated rats led to a significant reduction in available AR binding sites due to competitive inhibition. The findings suggest that spironolactone's antiandrogenic effects on the skin are likely due to canrenone's inhibition of the formation of specific testosterone or 5 alpha-dihydrotestosterone receptor complexes in the cytoplasm and nuclei.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 485 results
      Can I still save my hairline at age of 15?

      community Can I still save my hairline at age of 15?

      in General  471 upvotes 1 week ago
      A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductase inhibitors at this age.

      community It’s over. NOTHING has worked.

      in Chat  95 upvotes 2 years ago
      A user who has been trying various treatments for hair loss for four years, with no success. Suggestions include use of minoxidil, finasteride, RU58841, microneedling, supplements and multivitamins, lifestyle changes, scalp biopsy, and SMP.

      community Topical finasteride might be a lie

      in Research/Science 2 years ago
      The conversation discusses doubts about the effectiveness of topical finasteride for hair loss, suggesting that DHT could be produced elsewhere in the body and affect the scalp. It proposes that androgen receptor antagonists like spironolactone and clascoterone might be more effective as they could prevent this potential bypass mechanism.

    Similar Research

    5 / 1000+ results